Collectively, our data confirmed that in CRC cells ASTX660 (a) displayed no cytotoxicity as single agent, (b) acted as an antagonist of cIAP2, and (c) enhanced death receptor‐mediated cell death. The gene discussed is BIRC3; the disease is colorectal carcinoma.